Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Susan G who wrote (80977)	1/28/2000 2:19:00 PM
From: Jenna	Respond to of 120523

CYTC.. read this, for another perspective on the irrationality, this time the analysts, that can influence holding through earnings. One of my favorite trading stocks.. has given quite a few swing trades in the last 2 weeks. CYTC missed by 2 cents..Yesterday's drop made it obvious it was not a buy, nonetheless CYTC rose way above its morning lows for 47 11/16 and is now trading at 58 9/16. Cytyc misses Q4 EPS target, drops sharply BOXBOROUGH, Mass., Jan 28 (Reuters) - Shares in medical test maker Cytyc Corp. (NasdaqNM:CYTC - news) dropped sharply on Friday after its fourth-quarter profit fell short of analysts' expectations. Despite a big rise in earnings and revenues and a doubling of market share for its marquee Pap smear product, Cytyc's stock was down six at 58-3/4 in late morning trade. It had risen off a low of 47-5/8 earlier in the day. On Thursday the stock closed at 64-3/4. Late on Thursday, the company reported net income of 15 cents per diluted share on sales of $24.73 million in the quarter compared with three cents per share on sales of $14.63 million in the year-earlier quarter. [ed. comment any company we start should only do as well] The 1998 figure excluded a gain of $3.05 million from settling a lawsuit. Income from operations was $2.25 million compared with a loss of $386,000 in the year-earlier period. According to First Call/Thomson Financial, the average expectation among eight analysts polled was for Cytyc to earn 17 cents a share. A string of positive announcements in recent weeks led several analysts to raise price and earnings targets [Eds. Comment: here is our entry for "anticipatory upswing". on Cytyc and lifted hopes among investors of earnings that would top expectations. These included the recent news that Quest Labs has agreed to exclusively use the company's new improved Pap smear test for three years. Analysts were on a conference call with the company and could not immediately be reached for comment. [Ed. Comment. They are probably looking for a good 'comeback' after a ridiculous week of raising everyone's expectations than knocking them down again] or they are out buying SBUX.. which is up today ;-). So unfortunately following the trend, even though the course is plotted by the 'ignoramuses' among us, is our lot as traders. Fortunately we have learned to anticipate this.